Probing the Druggability Limits for Enzymes of the NAD Biosynthetic Network in Glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Probing the Druggability Limits for Enzymes of the NAD Biosynthetic Network in Glioma

Published:2016-04-18 Issue:5 Volume:56 Page:843-853
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Padiadpu Jyothi¹²,Mishra Madhulika¹,Sharma Eshita¹³,Mala Uchurappa⁴,Somasundaram Kumar⁴,Chandra Nagasuma¹

Affiliation:

1. Department of Biochemistry, IISc, Bangalore 560012, India

2. Supercomputer Education and Research Centre, IISc, Bangalore 560012, India

3. Oxford Genomics Centre, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX37BN, United Kingdom

4. Department of Microbiology, IISc, Bangalore 560012, India

Funder

Indian Institute of Science

Department of Biotechnology , Ministry of Science and Technology

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.5b00733

Reference63 articles.

1. Enzymology of NAD+ homeostasis in man

2. Sir2 Flexes Its Muscle

3. Pathway analysis of NAD+ metabolism

4. PARP-2, A Novel Mammalian DNA Damage-dependent Poly(ADP-ribose) Polymerase

5. CD38‐cyclic ADP‐ribose‐mediated Ca2+signaling contributes to airway smooth muscle hyperresponsiveness

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis;Frontiers in Oncology;2022-09-30

2. Glioma-Targeted Therapeutics: Computer-Aided Drug Design Prospective;The Protein Journal;2021-09-29

3. Identification of a co‐target for enhancing efficacy of sorafenib in HCC through a quantitative modeling approach;The FEBS Journal;2018-09-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3